“…These epigenetic modifications, which result in altered chromatin structure and gene expression were reported in different types of cancers [ 108 ] ( Figure 3 ). G9a was overexpressed in breast, gastric, ovarian, cervical, endometrial, prostate, lung, colorectal, liver, urinary bladder, and brain cancers, as well as in hematological malignancies, melanoma, and cholangiocarcinoma, leading to aberrant H3K9 methylation [ 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 ]. One of the main reasons for this increase in G9a expression and H3K9 methylation is hypoxia [ 103 ].…”